A randomised controlled trial comparing low dose vaginal misoprostol and dinoprostone vaginal gel for inducing labour at term

Authors: Gregson, Sarah1; Waterstone, Mark1; Norman, Ian2; Murrells, Trevor

Source: BJOG: An International Journal of Obstetrics & Gynaecology, Volume 112, Number 4, April 2005 , pp. 438-444(7)

Publisher: Blackwell Publishing

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Objective 

To compare the efficacy of low dose vaginal misoprostol and dinoprostone vaginal gel for induction of labour at term. Design 

A single-blind randomised controlled trial. Setting 

Antenatal and labour ward of a UK district general hospital. Participants 

Two hundred and sixty-eight women requiring induction of labour at term (>37 weeks of gestation) with no significant fetal or medical condition, no previous uterine surgery and no contraindication to prostaglandin. Methods 

Misoprostol 25 μg (one-quarter of a 100 μg tablet) was inserted into the posterior vaginal fornix every 4 hours (to a maximum of six doses) or dinoprostone vaginal gel 1–2 mg 6 hourly (maximum of 3 mg in 24 hours). Main outcome measure 

Induction-to-vaginal delivery interval. Secondary outcome measures 

Requirements for oxytocin, mode of delivery, number of women delivering <24 hours, incidence of uterine contraction abnormalities, incidence of abnormal cardiotocograph (CTG) recordings, 5-minute Apgar scores, umbilical cord pH recordings, analgesia requirements, admission to NICU and blood loss at delivery. Results 

There were no significant differences between the two groups in induction-to-vaginal delivery interval, mode of delivery, number of women delivering within 24 hours and neonatal outcomes. The incidence of uterine contraction abnormalities (tachysystole and hyperstimulation) and the incidence of abnormal CTG recordings were also similar for both groups. Conclusion 

Low dose vaginal misoprostol is as effective as dinoprostone gel for inducing labour at term. There would be substantial cost savings, estimated at around £3.9 million per annum, for maternity services if low dose misoprostol became the agent of choice for inducing labour in the UK.

Document Type: Research article

DOI: 10.1111/j.1471-0528.2004.00496.x

Affiliations: 1: Maternity Unit, Queen Mary's Sidcup NHS Trust, Sidcup, Kent, UK 2: Mental Health Section and Graduate Research Studies, Florence Nightingale School of Nursing & Midwifery, King's College, University of London, UK

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$50.16 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A